Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the SYNERGY trial

Harvey White, Neal Kleiman, Kenneth Mahaffey, Yuliya Lokhnygina, Karen Pieper, Karen Chiswell, Marc Cohen, Robert Harrington, Derek Chew, John Petersen, Lisa Berdan, Philip Aylward, Christopher Nessel, James Ferguson, Robert Califf

    Research output: Contribution to journalArticle

    75 Citations (Scopus)
    Original languageEnglish
    Article numberCC
    Pages (from-to)1042-1050
    Number of pages9
    JournalAmerican Heart Journal
    Volume152
    Issue number6
    Publication statusPublished - 2006

    Cite this

    White, H., Kleiman, N., Mahaffey, K., Lokhnygina, Y., Pieper, K., Chiswell, K., Cohen, M., Harrington, R., Chew, D., Petersen, J., Berdan, L., Aylward, P., Nessel, C., Ferguson, J., & Califf, R. (2006). Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the SYNERGY trial. American Heart Journal, 152(6), 1042-1050. [CC].